Hennell Medi Pharma Private Limited
About Hennell Medi Pharma Private Limited
Data last updated:
Hennell Medi Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the healthtech and medical tech solutions segment of the healthcare sector. It was incorporated on 01 April 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2010PTC201052.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹3.5 Lakh. It is led by directors including Archana Kumari and Chanda Narang.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D – 27 3rd Floor Green Park (Main), New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.6 Lakh, a growth of 106% compared to the previous year. For the same year it recorded a net loss of ₹62,423 (net margin -17.3%) and EBITDA of -₹62,423 (EBITDA margin -17.3%). Revenue has grown at a compounded annual rate (CAGR) of 114% over three years and 297% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hennell Medi Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD – 27 3rd Floor Green Park (Main), New Delhi, Delhi, India – 110016
- IndustryHealthcare, HealthTech & Medical Tech Solutions
To see the full contact details of Hennell Medi Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Hennell Medi Pharma Private Limited
FY 2024 filings availableHennell Medi Pharma Private Limited reported revenue of ₹3.6 Lakh (up 106% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 297% over five years, including 106% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹62,423 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹62,423 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -17.3% | ||||
| Net Profit Margin | -17.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hennell Medi Pharma Private Limited, buy the company report.
Board of directors of Hennell Medi Pharma Private Limited
Hennell Medi Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Kumari | Director | 25 Nov 2014 | 11 Years 11 Months | Current |
| Chanda Narang Also directs: Hennell Fine Collections Private Limited | Director | 01 Apr 2010 | 16 Years 6 Months | Current |
| Parmod Dutt | Director | 16 Dec 2022 | 3 Years 10 Months | Current |
Auditor
Hennell Medi Pharma Private Limited is audited by MITTAL JAIN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MITTAL JAIN & ASSOCIATES | FY 2023 | 025862N |
Shareholding
The shareholding of Hennell Medi Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hennell Medi Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hennell Medi Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hennell Medi Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hennell Medi Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hennell Medi Pharma Private Limited has 5 board changes on record since 2010: 3 appointments and 2 cessations. The latest: Yashpal Singh Bhati ceased to be Director on 28 Feb 2025.
Frequently asked questions
Hennell Medi Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in healthtech and medical tech solutions, within the healthcare industry. It was incorporated on 01 April 2010 (16+ years old) and is registered under CIN U24232DL2010PTC201052.
Hennell Medi Pharma has 3 current directors:
- Archana Kumari - Director
- Chanda Narang - Director
- Parmod Dutt - Director
The latest financial statements of Hennell Medi Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Hennell Medi Pharma is U24232DL2010PTC201052. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hennell Medi Pharma was incorporated on 01 April 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
Yashpal Singh Bhati ceased to be Director on 28 Feb 2025. Parmod Dutt was appointed as Director on 16 Dec 2022. Archana Kumari ceased to be Additional Director on 30 Sep 2015. Hennell Medi Pharma has 5 board changes on record in total.
The registered office of Hennell Medi Pharma is at D – 27 3rd Floor Green Park Main, New Delhi, Delhi, India – 110016.
Hennell Medi Pharma operates in the healthcare industry, in the healthtech and medical tech solutions segment.
The compliance status of Hennell Medi Pharma is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.
Hennell Medi Pharma can be reached at its registered office: D – 27 3rd Floor Green Park Main, New Delhi, Delhi, India – 110016.